FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Junichi Azuma

Research Profile

Chemicals & Drugs

Disorders

Physiology

Geographic Areas

Japan

Concepts & Ideas

Genes & Molecular Sequences

Genes, MDR

Occupations

Pharmacogenetics

Co-author Network

Publications

TOP 3
Masaki Kato; Masataka Wakeno; Gaku Okugawa; Tsuyoshi Fukuda; Yoshiteru Takekita; Yuka Hosoi; Junichi Azuma; Toshihiko Kinoshita; Alessandro Serretti
Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
Masaki Kato; Tsuyoshi Fukuda; Alessandro Serretti; Masataka Wakeno; Gaku Okugawa; Yuka Ikenaga; Yuka Hosoi; Yoshiteru Takekita; Laura Mandelli; Junichi Azuma; Toshihiko Kinoshita
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Masataka Wakeno; Gaku Okugawa; Y Takekita; Masaki Kato; Tsuyoshi Fukuda; M Yamashita; Y Hosoi; Junichi Azuma; Toshihiko Kinoshita
Delirium associated with paroxetine in an elderly depressive patient: a case report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Junichi Azuma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Masaki Kato; Masataka Wakeno; Gaku Okugawa; Tsuyoshi Fukuda; Yoshiteru Takekita; Yuka Hosoi; Junichi Azuma; Toshihiko Kinoshita; Alessandro Serretti
Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(4):1041-4.
2008: Masaki Kato; Tsuyoshi Fukuda; Alessandro Serretti; Masataka Wakeno; Gaku Okugawa; Yuka Ikenaga; Yuka Hosoi; Yoshiteru Takekita; Laura Mandelli; Junichi Azuma; Toshihiko Kinoshita
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Progress in neuro-psychopharmacology & biological psychiatry 2008;32(2):398-404.
2007: Masataka Wakeno; Gaku Okugawa; Y Takekita; Masaki Kato; Tsuyoshi Fukuda; M Yamashita; Y Hosoi; Junichi Azuma; Toshihiko Kinoshita
Delirium associated with paroxetine in an elderly depressive patient: a case report.
Pharmacopsychiatry 2007;40(5):199-200.
2007: Masaki Kato; Masataka Wakeno; Gaku Okugawa; Tsuyoshi Fukuda; Junichi Azuma; Toshihiko Kinoshita; Alessandro Serretti
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.
Neuropsychobiology 2007;56(4):167-71.
2006: Masaki Kato; Tsuyoshi Fukuda; Masataka Wakeno; Kazuhiro Fukuda; Gaku Okugawa; Yuka Ikenaga; Megumi Yamashita; Yoshiteru Takekita; Kenji Nobuhara; Junichi Azuma; Toshihiko Kinoshita
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.
Neuropsychobiology 2006;53(4):186-95.
2005: Masaki Kato; Yuka Ikenaga; Masataka Wakeno; Gaku Okugawa; Kenji Nobuhara; Tsuyoshi Fukuda; Kazuhiro Fukuda; Junichi Azuma; Toshihiko Kinoshita
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
International clinical psychopharmacology 2005;20(3):151-6.